Kymera Therapeutics KYMR
NASDAQ KYMR
$129.45 -5.39 (-4.00%)
As of: Nov 12, 2026 · 10:36 AM EST

Kymera Therapeutics (KYMR) Return on Capital Employed [ROCE] (2020 - 2026)

Updated

Kymera Therapeutics' Return on Capital Employed [ROCE] came in at -22.08% for Q2 2026, up 11.20 percentage points from -33.28% a year earlier but down 0.23 percentage points from the prior quarter.

Analysis

Kymera Therapeutics (KYMR) Return on Capital Employed [ROCE] (2020 - 2026) Analysis & Trends

For FY2025, Kymera Therapeutics' Return on Capital Employed [ROCE] was -27.36%, up 9.54 percentage points from FY2024.

  • Return on Capital Employed [ROCE] carries a five-year change of -3.15 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -36.90% in FY2024 (-4.04 pp), -32.86% in FY2023 (-2.61 pp), -30.24% in FY2022 (-8.10 pp) and -22.14% in FY2021 (+2.06 pp).
  • The five-year range for quarterly Return on Capital Employed [ROCE] is -36.68% (Q3 2023) to -17.87% (Q3 2021).
  • Year-over-year, Return on Capital Employed [ROCE] has increased for three consecutive quarters, with an average year-over-year change of +2.48 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q3 2024 (a gain of 13.50 percentage points), and the weakest in Q3 2022 (a drop of 14.11 percentage points).
  • Business Quant data shows KYMR's Return on Capital Employed [ROCE] at -21.85% (Q1 2026), -26.09% (Q4 2025) and -31.80% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Kymera Therapeutics 11.66 Bn 8.50 Bn - -25.05%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -25.05%
Jun 30, 2026 -22.08%
Mar 31, 2026 -21.85%
Dec 31, 2025 -26.09%
Sep 30, 2025 -31.80%
Jun 30, 2025 -33.28%
Mar 31, 2025 -31.29%
Dec 31, 2024 -27.87%
Sep 30, 2024 -23.17%
Jun 30, 2024 -23.64%
Mar 31, 2024 -26.74%
Dec 31, 2023 -34.60%
Sep 30, 2023 -36.68%
Jun 30, 2023 -31.70%
Mar 31, 2023 -31.04%
Dec 31, 2022 -29.35%
Sep 30, 2022 -31.97%
Jun 30, 2022 -30.80%
Mar 31, 2022 -25.05%
Dec 31, 2021 -18.91%
API Access

Kymera Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=KYMR&period=max&api_key=YOUR_API_KEY